PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Romiplostim - Immune thrombocytopenia

PAD Profile : Romiplostim - Immune thrombocytopenia

Keywords :
ITP, NICE, TPO Agonist
Brand Names Include :
Nplate

Traffic Light Status

Status 1 of 2.

Status :
See Below
Formulations :
  • Not Specified
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 2 of 2.

Status :
Red
Formulations :
  • Not Specified
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

No indications returned.

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
04 September 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) approves the updated ITP pathway.

03 June 2020
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

ITP treatment pathway has been updated to include sequential use of eltrombopag & romiplostim

Associated BNF Codes

09. Nutrition and Blood
09.01.04. Drugs used in platelet disorders
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More